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end TEL (5 aches), The rate of EGGs ordorad was also not different, (P - 
034) 
Conclusion: Tolemediclne interactive cardiology evaluations provide cltn. 
Ically accurate Information, but Important differences between TEL and FTF 
exist, A~urato lelomedlclne cardiology may be podormod without echo in 
many pediatric patients, 
~ Tolomedlcsl Interpretation at Neonatal 
Echocsrdlogrema: Impact on n General Podiatric 
Practice 
G,R, Rtlndolph, P,W, O'Le~tW, B,K, KhandhaflA, D,J, Hauler, J,B, Seward, 
M~/o C/in~e, Rochester' Mlnnpsof~, USA 
~la~Qml/~t; Cardiology amvl(~et, can be dllflcull to provide in nlrol eros#, This 
study was performed to evaluate the InterpretAtion ~t remote site neonatal 
o0horArdlogmms using teal-lima talamedletne, 
M~fhoda,' Adult aonagmphem psdormed studios requestnd by general 
pedllllflctana At a site 3BO miles from th~ potll~lrlC ollrglolegy ~enter (hub), 
PrellmlnAty images ware recorded ~nd transmitted from onba~da to A pediAlna 
~hoosrdlologtM ~t the hNb ~.Ising AT,1 system (1 ,B megabitslaee), Additl,.)nal 
teal,lima scans ware then dlrofltod end mnnltored by the reviewer to complete 
each .tudy, 
R~lte:  115 T,1 n0,bo~ardlograms ware pedormod on g0 neonAleS, Me, 
dian age was ~ days, 90% (89/90) oi initial erho~ardlograma were pedermod 
u~nlly or emergantly, Tmnsmltled Imegaa provided Adaq~nto diagnnstic in- 
formation in all pts. T.1 diagnoses ware confirmed in ~II pie with nubseqtmnt 
slandard !eating (N ,= 12), T.I echo findings dtanged medical management 
nr outpatient followup In 61% (aS/SO), An Immediate change in management 
o~urred qn 26% (23/90), B babies were itavcroly m/Anotlo And 1 was hypoten- 
slw due to CHD (Congenital Heart Disease), %1 echo findings guided local 
stsblllzafton and eady transfer in 4, Unnecessan/transfer was avoided in 2 
cyanntie n~nates whose cardiac mallormatlons ware not doers1 dependent. 
Con~uston: 1",1 echo provides accurate diagnostic data tn neonates, 
Rapid tale.diagnosis facilitates cam oi sick neonates with possible CHD 
In the pitman/care se~11ng, Unnecossaw long distance transfers can be 
avoided, Reel.time, teto.echo~ardlography etle~tlvaly extends tortlaq/pedi. 
Atdc cardiology Into prtmaq/caro settings, 
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11172-53 J influence of Anglotensln on ANP Release and 
L . . - - - - - - -  
- ' Renal Response to Volume Expansion In 
Moderate Heart Failure 
R, W(llenbrock, M, Scheuormann, G. Thlbault, R. Diotz. 
Fran,.',.Vo/h~rd.Klinik, Bert/n, Germany 
In heart failure, the release of ANP is impaired along with an activated 
renin-anglotonsin system, We tested the hypothesis that ANP release is 
angiotensin It- dependent and studtod the effect el ACE-inhibition (ramiprilat 
50 m.0,/kg) and ATl-blockade (valssrtan 0.3 mg/kg) on ANP release and on 
the renal response to acute volume expansion (5 ml/5 mln hyperoncontic 
solution) in rats with shunt-induced moderato heart failure. 
ANP plasma levels were increased in shunted rats (397 ~ 39 pmoR 
vs. 55 ~ 8 in controls rats, p ~ 0.001) at baseline. Alter acute volume 
expansion, the ANP release was impaired In shunted rats (68 L 4 vs. 135 
7 pmel/1, p .  0.05). Natriurests and diuresis were blunted at baseline and 
after acute volume expansion (1250 ~ 126 vs. 2753 L 1;6 .I/60 min, p .  
0.001). ACE-Inhibition end ATl-antagonlst did not influence hemodynamic 
parameters. Acute ACEI increased natnuresis end diuresis at baseline in 
heart failure rats compared to placebo treated rats (211 50 vs. 95 ~ 15 ttl/20 
mln, p -- 0.05). After acute volume expansion, ANP plasma levels significantly 
increased with ACEI end ATl-antagonist in shunted rats, inducing a further 
release at 190 9 i- 86.9 and 250,0 :t: 48.5 vs. 67.7 :~ 32.8 pmol/I with placebo 
(p < 0.05). N-terminal ANP increased similarly, confirming that the release of 
ANP was modified. Natdurosis and diuresis were enhanced by ACE-inhibition 
(2345 -L 332) and ATl-blockade (1860 :t 180 vs. 1250 ~. 126/=L'60 min, p 
• 0.01). Our results demonstrate that acute anglotensin inhibition restores 
ANP release and renal responses alter acute volume expansion in shunted 
rats. This suggests a new site of interaction between the angiotensin and the 
ANP system. 
• Renln-Anglotensln Inhibition Prevents System 
Early but Not Late Remodeling of the Left 
Ventricle In Pacing.induced Cardlomyopsthy 
H, Knwal, A, Mohan, C, Ltang. University of Rochester, Rochester, NY, USA 
B~ckground: The ronin.anglotensln system (RAS) play~ an important 
in leH ventdeular (LV) remedellng In congestive heart failure (CHF); how- 
ever, the results of RAS inhibition on LV remodeling have been coolltrtin9 
We speculate that the differences in results may be related to timing oi 
Interventions In CHF, 
Mefhod~: To study whether the eff~¢la of RAS inhibition may differ at van- 
cue stages of development o! CHF, we. measured LV end.diastolic d imen~ 
(EDD, ram) end LV fraalional shortening (FS, %) before (B) And Alter 2, 
4, 6, 8 weeks of pl'!elng.lnduced CHF (360 bpm for 8 wQ~_ka) in ¢on.soou~ 
rabbits, RAS inhibition wAS achieved by administration oi both quinapnl (Q, 
10 mg/kg), an anglotensin.convertlng enzyme inhibitor and foMrtan (L. 50 
mg/kg), an AT1 engiotansln II receptor bl(,~kat, 
Re-~t~/fsl.' V~tuoa worn compared to Sham and untreated CHF animals 
ChAnBos in EDD . ChAnl~a in F$ 
(mm)j eP  (~,1 , . . ,  ~ 
II 2w 4v~ 6~, Rw II 2w 4w 6w #~ (N=¢'me=:klP°qP) 
Conc/u.won, Rapid ventoculat pacing produces acute LV dilabon and 
systolic dyslunclion, RAS inhibitmn delays the onset of these changes m 
eady CHF, but deos not prevent LV remodeling in chronic CHE 
• Anglotensln II l~tpe Receptor 1 Blockade: 
Myocardial Fibrosis, Stiffness, and Flmction After 
In|station In the Rat 
H,M. That, H.H.T. Van, MA. GabeUa, S. Goldman, T.E Rays l'bcson VAA~ 
,'zna Umve~it)' Heart Centre bnlversily ot Arizona. 7boron. AZ. USA 
Background: We examined the effects of specific angiotensm It type 1 (AT1) 
receptor blockade on myocardial fibrosis, stiffness, and function after my- 
ocardial infamtion (MI) in the rat. 
Methods and Results: Rats were randomized to Iosartan or placebo 1 day 
alter MI and treated for 8 weeks. In sham and MI rats Iosartan decreased 
(P ~ 0.05) LV and RV weights, mean aortic and LV systolic pressures. 
LV end-diastolic pressure iEDP) was increased (P < 0.05) tn MI vs sham 
rats. Losartan decreased (P -. O05) LV-EDP in MI but not m sham rats. 
Maximal developed tension (DT) and peak rate of tension nse (+dTidt) were 
decreased (P .  0.05) in MI vs sham (DT: 1.64 ~ 0.46 vs 3.45 • 1.11 oj'mm z: 
dTldt: 15.9 ~ 44 vs 345 ± 12.0 oj'mm~/sec). Losartan decreased DT and 
+tiT/dr in sham rats and increased DT and +dTldt in MI rats resulting in a 
significant interaction (P = 0.043 and P = 0.045, respectively). The peak rate 
of tension decline decreased (P - 0.05) in MI vs sham rats ( 10.6 ± 3.8 vs 
- 16.2 ~ 5.4 g/mm~/sec) with a trend to iocreaso by Iosartan in MI rats ( 2.5 
5.1 gtmm'~/sec). Interstitial fibrosis increased (P < 005) in MI vs sham 
and decreased (P < 0.05) with Iosartan. Ik%'ocardiat s iffness increased (P - 
0.05) after MI but normalized (P .: 0.05) with Iosartan. 
Conclusions: Alter MI, ATt receptor blockade has benehcial effects on my- 
ocardial contractility and normalizes myocardial stiffness with an assocmted 
reduction in myocardial fibrosis. 
• Angiotensin Converting Enzyme Inhibition 
Increases Cardiac Adenylycyclase Expression in 
Congest;ve Heart Failure 
T, Anzai, M. Gao. NC. Lai, HK. Hammond. VAMC-San Diego and UCSD. 
La Jolla. CA. USA 
Background: Heart failure is associated witn aec~eased adenylycyclase iAC) 
activity and downregutaticn o! AC mRNA. particularly type VI (ACw). The 
effect of ACE inhibition on AC, a pivotal regulating element in transmembrane, 
signaling, is unknown. 
Methoos: We studied 23 pigs (51 ~.- 6 kg): 11 controls: 6 received no 
treatment (CON) and 5 received lisinopdl iLlS, 0.5 mg/kg/d iv for 10d) and 
12 paced from the LV (220 bpm, 20d): 6 received no treatment (HF) and 6 
received Usinopril for the final 10 days (HF/L). Heart failure was documented 
(pacers off) by decreased LV fractional shortening (p < 0.001 ) and increased 
left atrial pressure (p < 0.001). We measured LV AC activity, and mRNA 
content of ACw, the predominant AC isoform in pig heart. 
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l i !% llqi I #lil~ 
i%*,,il I,Iii% * l~!llltil!l ~ /i~IF~l 
t I )% I I% lit Ill ,1 
Re~u~ •Tmm~l peg~ wdh he~q f~um wm~ Immo~t *n~m¢l  ~Ol~O- 
lefeno~ (HF vs HF/L t~L~ ~ 33 Vlz 194 ± 33 ~ r ~  p ,~ 0,01) a~ 
to~k0lm~ (HF vs HF/~ ~74 ~ 71~ v~ 390 ~ 66 pm0~n,  P ~ 0,01) 
14m~lMed AC a ~  and mslomd ACVI mRNA e ~  1o nom~L ACI~ 
ak,r~ ~ no ~ o#t AC ~ and ACVI mRNA eqvpm,~lon. 
~ '  ACE ~ in heat ~ m~)ves pAR signaling, m perL 
!twough ~ AC~ e ~ .  
• Angk~en!in n Cm~tm~ Io Clmk~ 
Olple!bn Outing Oevelopment of 
ConguUVe Ne~ ~ FaUu~ me
H Kawm. A Moha~ J . ~  J.A~mstmng, CIJang L ~ o t  
Backgeoun~ A n ~  II (All) m known to mmtulam nomlPmepimne (NE) 
m~l~e a,'~l uplallm m ftle sympalha~ ~m~e terminals, bul whet~er All 
~ ~O ca~iac NE ~ nt ce~esave hea~ fadum (CHF) is nol 
known. 
A ~ -  We admmm~end I~e " enzyme 
qU~ (O, 10 n~/kg) ~ ~ ATT All r~T~ block~ Iosa~an (L, 50 
moj'kg) IO 6 mUI~s w~l ~ (3~0 bpm) CHF for B weeks. Resufts 
were compared to 6 sham controls a~d 6 untmatod CHF ~ .  We mea- 
s~,ed LV end-dmsto~ dmensmn (EDD, ram), LV fra~-q~qai ~- ,0  (FS. 
%). LV end.-dklstOt~ (EDP, nm~-Ig), myocanial NE upt'~. 
(fmo~m~15 ram) and cantac sympalhal~ NE prone rang sucrose--putes- 
s~m ptmsphate..g~:,(y~ aod-mduced tustofluonsce,-~e (ceunts,x~=l~. 
Resu~: 
EDO FS EDP NIE uptake NE profile 
148 ~' 03  37z2  8~1 t19~ 1O 1a3~7 
CHF 178±105"  17¢t"  23~4" 624:6" 1001:9" 
CHF~Q÷ L 17.0±04" 21 - '2" 15 *--2 126 z: 121" 185 = 121" 
V',~t~=s alre meaen~ ± SE : 'p  • O05vS.  Sn~m.  l"p ~ 0 05v~ CHF 
RAS ~ prevented reduc'boos of NE uptake ~ and NE pnfile 
during devolet3ment ot CHF. Its effects on card~c muscle funct~n were 
re~-=~y smaa. 
~ :  RAS m~bttmn presences the Integrity of the cardiac ~ -  
thetic newe termmats m CHE This ~ may contnbute to dm~cal benefioal 
effects of RAS inhlbdloo in CleF. 
-~ '~ Scar Shrinkage: A Novel Treatment for Ventricular 
Aneurysms 
P. Wh~taker. The Hearlr f~ .  C-ood Samaritan ~ & Unwer~ty ot 
Soumem ~ Lo~ Amgek~ CA. USA 
Backgeound." Large increases m left ventncular (LV) ca w volume after my- 
ocardtal infarct~n can lead Io head failure and death. Reversal of volume 
increases by excismn of the expanded scar and subsequent reconnection of 
viable myocan:lium ay result in signtr, cant ca~ac distortion. Scar exctSmn 
followed by insertion of a prosthetic graft restons the original geometry; hew- 
ever. introduces foreign materials into the body. A method of reducing cap, nty 
volume without such pnblems was attempted by shJnLing the aneurysm 
with laser energy. 
Methods: Rats (n = 14) underwent permanent coronary occlusion and 4 
weeks later were nndomized to either control (no treatment) or la~er therapy 
(irradiation of the surface of the scar until shnnkage was apparent). Thirty 
minutes after treatment, the hearts were removed, fixed at a distending 
pressun o! 15 mmHg, and the LV cavity volume measur~":l.. Intact size 
(assessed from the amount of remaining muscle) and scar thickness were 
measured from histologic sections, as was the extent of thermal effects and 
the waviness of the collagen fibers. 
Results: Both groups had similar sized large infarcts (P = NS). However, 
then was a 25% reduction in LV cavity volume from 0.72 :k 0.07 mL in controls 
fo 0.54 ~ 0.05 mL in laser-treated hearts (P < 0.05). Also, scar thickness was 
gnater in laser-treated hearts (550 ± 50pro) than in controls (360 ± 40/=m, P 
< 0.02). Laser treatment resulted in thermally induced shrinkage of collagen 
fibers in the aneurysm. The fibers directly affected appeared less bnght than 
controls wren V~Ned with IX~r~zed Itgtlt (an nldca~:~ of ir, cma~d ~ .  
aturo) and wen also shod~ ~ stra~lht~r than ~naL  Futlt'4mIx~e, ven 
fiber= ~mlfected by the ~"npprmuro i~crea~e wrm sTntgntef lhan nom~ 
C"~qs:  EJq~anamn of the infafctt~ Vemtr~ emd thmfling of ff~ wa~t 
can b~ mwmed t~ thermally,medlMed shnnksge Of CoJiagen fibe~ wflt~n tt~ 
sCar~ Sucl~ favorable vem~ui~ mmodelicg was ech~t  ~ 
of the ventricle red witho~ the ue~ Of pro~he~ malenal, ~ Io~-lem~ 
eff¢,'¢Y of ~s  la~e, 1 ~ t  ~ m  wom~y M fwthm ~ .  
Cerd l~pu lmonary  and  Ventdcut l r  
Int~ractlonl  in Hear t  Fat lum 
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ea .um:  Cha! l l¢~f tnt lon  and Effect M Amledlplne 
R. ~ ln ,  S. I:10~, A Millet', G, Neul~rg, V I~,rmiem, D. Fed, J Lento, 
E Mohter, B fiusse~, M Zile, A Cropp, C. D im/For  me PRAISE 
m~m~tor~ New York A~ed CoU New Vo~, New ~o~C USA 
White amJo~ (AMLO) had a neut~l elfecl o~ overall moraMy and lecl to 
~c'ma~d me~a~, among pa~e~ (pts) w~ no.scampi co~om,mpa~y 
(CM) m PRAISE, (AMLO) we= assoc~led with mcnase~ number of 
PuJmonaW edema events (PE~). To ~ eluc¢late em appamm assocla- 
~on bellmen AMLO and mcn~sed PEI. m mmnts wem chamclmized 
and ~lass~ed using pmspecttied ¢finK~ crite~a m a blinded ~ .  pts 
with PEs Imaled with AMLO ~r PL (~d not ~fte~ w~h mga~ to ~ 
features, heserme NYItA clan. qectmn fracl~n or nonca~¢fmc lnggers. Pm- 
Por~o~ ol pls w~h PEs who had mchem CM did not (~er for AMLO (0.67) 
o~ PL (0.66). Using pu~random,~tion Man~-Bayer su~al  c .~m for I~  
~m PEs on both AMLO and PL, I1 ~ dBchne m survival (50%) Over Itm 
hrS. 3 ~ ~; di~le,,'1~l. By appmmmate~ I year, .~urv~val ~ tot pls 
wilh PEs paragel pts w#nout PEs. Among pts w~th ~ wflhout PEs, pls on 
AMLO had n,npmved sunmral. Excess PEs for AMLO ~ PL using b~ded 
re~ass~N:ation (8.4 vS 6_5%) w~ sim~lar to ~ seen for pn~ ffwestigator 
events (11A ~ 8.8) or for PRAISE adludicated endpoints. (6.1 vs 
26%) 
Co~lus~n: The mcreasecl PIE's m AMLO I~S m PRAISE is unexplained 
by clir~cal c h a ~ ,  mck~nng ~sce~c e~meo~ o,r me c~e~a by wh~,h 
PEs an  defined. Pts with PEs on AMLO have ~ sunnval compared 
wffh those on PL 
~ ACIE-Inhibiflon Improves the. Pulmonary Diffusion 
in Heart Failure by Reducing the EIcesslve 
Alveo lar -CN~my Memmne Diffushm Res;~;i~ce 
M. Guaz~. P.G Agostoni. M.D. Guaz~. Instrrute ot CanlK)lo~, Lh,;,~,sn'y ot 
Mdar~ CN.R. Milan. tlaly 
Oblecfwes: TINs study was am~ed at investigatir~g the mechanisms whereby 
ACE-int~b~on Fnl~ove the reduced pulmonary diffusing capacffy for cad~n 
monoxide (Dlco) in chrorec head fmlure (CHF). 
Background: Ah,,eolar-capdlary membrane conductance (DM) and cap- 
irlary blood ~olume (Vc) are tho s u ~ t s  of Dlco. In CHF, stret~ 
failere of the rnembrane provides a pessible mechanism for reduced DM and 
subsequent impairemem of Dlco. 
Mefho0~: 27 iTdt~ents wffh NYHA class II to lit CHF and 14 age-and 
sex-malched non.el sub]ects underemnt pulmonary foncbon Testing ~ 
determmason of DM and Vc eccom~ng to the cla,ss¢ Rougt~on and Foster 
method, whik~ receiving placebo and 48 hours and 8 weeks after starling 
enalapril tnalment (10 mcj b.Ld.). 
Resuffs: Enala~onl was ~efteclwe in controls at both short and mid-term. 
In CHF, the only change observed at short.ter'~n was a reduc~on m Vc (from 
134.5 ± 49.5 to 120 ± 36.2. p < 0,05) (likely consequence of a decrease 
in capillary pulmonary pressure). At mid.term DM was greatly rained (from 
29.51 ~ 8.0 to 36.9 ~: 8.9 ml/min,'mmHg, p ~ 0,01) even when the effective 
alveolar volume (Val was accounted for (DM/Va) resulting in a significant 
improvement in Dlco (form 22.1 ± 6.7 to 25.2 ± 5.5. mVmtn/mmHg, p < 
0.01), desptto a decrease in Vc (from 134.5 ± 49.5 to 101.3 ± 44.2 ml, p < 
0.01). The delay in DM improvement suggests the emergence of a gradual 
speofic modulatory effect of ACE.inhibition on the membrane function, which 
is likely disr~oafed from changess in pulmonary capdlary pressure and Vc. 
Conclusions: CHF causes an increase in diffusive resistance through 
derangement of alveolar-capillary interface. ACE-inhibition restores the dif- 
fusive propen'~es of the membrane and gas transfer, and protects the lung 
when the head is failing. 
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